FDA Enforcement Class II Terminated

TotalCare SpO2RT2 bed. Product Usage: Bed, flotation therapy, powered bed may be used in a variety of settings including, but not limited to, acute care, including critical care, step down/progressive care, medical/surgical, high acuity sub-acute care, post anesthesia care unit (PACU), and sections of the emergency department (ED). The TotalCare SpO2RT¿ 2 Bed System is capable of being used with a broad patient population as determined appropriate by the caregiver or institution.

Recall: Z-0949-2013 · Reported March 20, 2013

Enforcement

Recall Number
Z-0949-2013
Event ID
64580
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Hill-Rom, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Report Date
March 20, 2013
Initiation Date
February 26, 2013
Classification Date
March 14, 2013
Termination Date
April 16, 2014
Address
1069 State Route 46 East, N/A, Batesville, IN, 47006-7520, United States

Description

TotalCare SpO2RT2 bed. Product Usage: Bed, flotation therapy, powered bed may be used in a variety of settings including, but not limited to, acute care, including critical care, step down/progressive care, medical/surgical, high acuity sub-acute care, post anesthesia care unit (PACU), and sections of the emergency department (ED). The TotalCare SpO2RT¿ 2 Bed System is capable of being used with a broad patient population as determined appropriate by the caregiver or institution.

Reason

In certain situations a software problem with the TotalCare SpO2RT¿ 2 bed may occur that can lead to inadvertent loss of sufficient surface cushion pressure to adequately support the patient. This may increase the likelihood of skin irritation for patients at higher risk of developing pressure-related skin conditions. A correction to the software program is currently being developed and tested,

Code Info

S/N between N230AM1358 & O023AM3687.

Distribution

USA Nationwide Distribution including the state of Canada

Quantity

309